These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 1913960

  • 1. [Effects of nifedipine on pulmonary hypertension in patients with chronic obstructive pulmonary diseases--a comparison with oxygen administration].
    Liu Z, Yu RJ.
    Zhonghua Jie He He Hu Xi Za Zhi; 1991 Jun; 14(3):146-8, 189. PubMed ID: 1913960
    [Abstract] [Full Text] [Related]

  • 2. [Variable hemodynamic response to nifedipine in pulmonary hypertension secondary to chronic obstructive bronchopathy and pulmonary fibrosis].
    Domenighetti G.
    Schweiz Med Wochenschr; 1985 Sep 28; 115(39):1345-7. PubMed ID: 4071009
    [Abstract] [Full Text] [Related]

  • 3. [Vasodilator therapy in pulmonary hypertension and chronic obstructive lung disease (COPD). Hemodynamic studies exemplified by nifedipine and nitroglycerin].
    Gassner A, Fridrich L, Magometschnigg D, Sommer G, Klicpera M.
    Herz; 1986 Aug 28; 11(4):207-16. PubMed ID: 3093345
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Acute and long term effect of nifedipine on pulmonary hypertension secondary to chronic obstructive airways disease.
    Johnson DC, Joshi RC, Mehta R, Cunnington AR.
    Eur J Respir Dis Suppl; 1986 Aug 28; 146():495-502. PubMed ID: 3465575
    [Abstract] [Full Text] [Related]

  • 6. Acute effects of nifedipine administration in pulmonary haemodynamics and oxygen delivery during exercise in patients with chronic obstructive pulmonary disease: implication of the angiotensin-converting enzyme gene polymorphisms.
    Kanazawa H, Tateishi Y, Yoshikawa J.
    Clin Physiol Funct Imaging; 2004 Jul 28; 24(4):224-8. PubMed ID: 15233837
    [Abstract] [Full Text] [Related]

  • 7. [Clinical and hemodynamic evaluation of 6-week treatment of pulmonary hypertension in chronic obstructive lung diseases (COLD) with low dose of prazosin].
    Lewczuk J, Spikowski J, Sobkowicz-Woźniak B, Porada A, Wrabec K, Trzesicka M, Piszko P, Palka PS, Szczygielski J.
    Kardiol Pol; 1990 Jul 28; 33(6):358-64. PubMed ID: 2084301
    [Abstract] [Full Text] [Related]

  • 8. Two-week nifedipine treatment for pulmonary hypertension complicating chronic obstructive lung disease.
    Saadjian A, Philip-Joet F, Guintoli A, Torresani J, Arnaud A.
    Eur J Respir Dis; 1985 Nov 28; 67(5):346-50. PubMed ID: 4085586
    [Abstract] [Full Text] [Related]

  • 9. Hemodynamic effects of nifedipine in pulmonary hypertension.
    Klugmann S, Salvi A, Fioretti P, Camerini F.
    G Ital Cardiol; 1982 Nov 28; 12(7):505-8. PubMed ID: 7169146
    [Abstract] [Full Text] [Related]

  • 10. [Effects of nifedipine in patients with unstable chronic obstructive pulmonary disease].
    Seoane M, Verdejo J, Sandoval J, Lupi E.
    Arch Inst Cardiol Mex; 1986 Nov 28; 56(2):109-16. PubMed ID: 2942120
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Long-term treatment of pulmonary hypertension in chronic obstructive bronchopneumopathies with nifedipine. Hemodynamic study over 18 months].
    Saadjian A, Philip-Joet F, Vestri R, Arnaud A.
    Ann Cardiol Angeiol (Paris); 1989 Apr 28; 38(4):197-202. PubMed ID: 2735734
    [Abstract] [Full Text] [Related]

  • 14. Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with chronic obstructive pulmonary disease. A controlled double-blind study.
    Kennedy TP, Michael JR, Huang CK, Kallman CH, Zahka K, Schlott W, Summer W.
    Am Rev Respir Dis; 1984 Apr 28; 129(4):544-51. PubMed ID: 6711997
    [Abstract] [Full Text] [Related]

  • 15. [Value of nifedipine in respiratory failure related to obstructive chronic bronchitis during treatment over 6 months].
    Meurice JC, Boutaud P, Herpin D, Ingrand P, Boita F, Underner M, Patte F.
    Ann Cardiol Angeiol (Paris); 1989 Mar 28; 38(3):171-7. PubMed ID: 2735732
    [Abstract] [Full Text] [Related]

  • 16. [The effects of diltiazem on pulmonary hemodynamics and oxygenation in copd induced pulmonary hypertension].
    Fang B, Wang C, Dai H.
    Zhonghua Yi Xue Za Zhi; 1998 Oct 28; 78(10):779-81. PubMed ID: 11038835
    [Abstract] [Full Text] [Related]

  • 17. [Hypoxic pulmonary hypertension: nifedipine therapy].
    Agostoni P, Doria E, Galli C, Tamborini G, Fiorentini C, Guazzi M.
    Cardiologia; 1988 Oct 28; 33(10):961-9. PubMed ID: 3233606
    [No Abstract] [Full Text] [Related]

  • 18. [Favorable response of pulmonary hypertension in patients with chronic obstructive airway disease treated with diltiazem].
    Gassner A.
    Schweiz Med Wochenschr; 1984 Mar 10; 114(10):332-7. PubMed ID: 6710104
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Transient effect of nifedipine on pulmonary hypertension of systemic sclerosis.
    Fudman EJ, Kelling DG.
    J Rheumatol; 1985 Dec 10; 12(6):1191-2. PubMed ID: 4093929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.